After the successful setup of the MediCrops group and the acquisition of the production site, 100% self-financed by the Founder, MediCrops Holding AG opens the first financing round for external investors. With the Series A Funding, limited to a volume of CHF 4.20 million, investments are now being made in equipping the production plant with high-performance technology. This includes on the one hand the clean room implementation for plant cultivation, on the other hand the setup of an in-house laboratory and the purchase of a sophisticated CO² extraction plant for the production of precious oils and concentrates.
The first MediCrops site in Macedonia will have a yearly production output of 20,000 KG cannabis flowers and a capacity to produce 3,000 litres of cannabis oil. This is currently equivalent to a market value of 100 million euros.
Well invested money!